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A b s t r a c t
Background: During pregnancy the cardiovascular system undergoes complex alterations; however, there have been few 
studies concerning pulmonary artery behaviour during gestation. 
Aim: The aim of this study was to evaluate changes in the pulmonary artery diameter (PAD) during gestation, with respect to 
left ventricular (LV) load and remodelling, as well as to systemic vascular resistance (SVR). 
Methods: It was a prospective cohort study, which included 69 consecutive healthy outpatient women with a singleton 
pregnancy. Echocardiography and ultrasonography of the uterine arteries were performed at two visits (V1 and V2) during 
pregnancy, and only echocardiography at one visit postpartum. 
Results: Pulmonary artery diameter increased in all women, from 20.0 mm at V1 to 22.7 mm at V2 (p < 0.001), and it returned 
to the reference range postpartum (19.5 mm; p < 0.001 vs. V2). Echocardiography did not reveal any other abnormalities, includ-
ing the signs of intracardiac shunt or right ventricular pressure overload. During V2, PAD positively correlated with the following 
echocardiographic parameters: LV end-diastolic diameter (r = 0.386; p = 0.002), LV end-systolic diameter (r = 0.345 p = 0.006), 
LV end-diastolic volume (r = 0.308; p = 0.016), LV mass (r = 0.459; p < 0.001), left atrial area (r = 0.334; p = 0.009),  
LV cardiac output (r = 0.338; p = 0.011), and aortic diameter (r = 0.369; p = 0.003). Furthermore, there was a negative linear 
correlation between PAD and SVR (r = –0.307; p = 0.025) and pulsatility index (r = –0.318; p = 0.012).
Conclusions: Our study shows pulmonary artery dilatation in healthy pregnant women without any other abnormal echo-
cardiographic findings. These changes in PAD are associated with volume overload and low vascular resistance, and during 
postpartum they usually subside.
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INTRODUCTION
A proper adaptation of the cardiovascular system during preg-
nancy is essential to cover higher metabolic demand of both 
the mother and the foetus and to provide sufficient uteropla-
cental circulation. Pregnancy is characterised as a high-volume, 
low-resistance state [1], during which systemic vasodilation 
occurs at five weeks after conception and reaches the nadir in 
the middle of the second trimester (decreasing by 35% to 40% 
of the baseline value) [1]. The plasma volume starts to increase 
at between six to eight weeks and continues to rise until 28 to 
30 weeks of gestation. The increase is mediated by complex 
changes in the endocrine system that lead to hyponatraemic 
hypervolaemia [2]. These changes in blood volume cause heart 
adaptation in terms of a mild four-chamber dilatation and 
a progressive increase in cardiac output due to an early increase 
in stroke volume and subsequent increase in heart rate [2, 3]. 
What is more, aortic distensibility is increased during normal 
pregnancy and manifests as a mild increment in aortic diameter 
during the second trimester in comparison with non-pregnant 
women. The mechanism by which the aortic stiffness decreases 
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is unrelated to mechanical stress and is probably the result of 
intrinsic changes in the aortic wall, mediated by high blood 
levels of oestrogen [4, 5].
Data concerning the adaptation of the pulmonary artery 
to healthy pregnancy are scarce. Therefore, the aim of this 
study was to evaluate changes in the pulmonary artery diam-
eter (PAD) and their correlations with cardiac remodelling and 
haemodynamic parameters throughout gestation. 
METHODS
Study population
Our research was designed as a prospective cohort study. 
A total of 86 consecutive healthy outpatients with a single 
pregnancy confirmed during an obstetric visit were enrolled 
in the study between 2014 and 2015 in Brzesko, Poland. 
The exclusion criteria were as follows: 1) any cardiovascular 
and pulmonary disorders that could contribute to pulmonary 
artery dilatation, which were diagnosed before or during preg-
nancy, including hypertension, venous thromboembolism, 
cardiac surgery, or chronic pulmonary diseases (e.g. asthma, 
sarcoidosis), and 2) gestosis in previous and present pregnan-
cies. Women were also asked to present all blood test results 
performed during pregnancy. 
Three visits were scheduled during the study:
 — baseline visit (V1) at the end of the first trimester (between 
weeks 10 and 14);
 — second visit (V2) between the second and third trimesters 
(between weeks 25 and 30);
 — follow-up visit (V3) postpartum (between weeks 
12 and 38).
The time of the visits during pregnancy was chosen to 
show changes in blood flow in uterine arteries.
All participants gave their written informed consent to 
participate in the study. The study was approved by the Local 
Ethics Committee, and the study protocol complied with the 
Declaration of Helsinki.
Clinical examinations
History taking and physical examination were performed dur-
ing all three visits. Among others, blood pressure and weight 
were measured, and body mass index was calculated (as 
weight in kilograms divided by the square of height in metres). 
Blood pressure was measured before echocardiography, after 
five-minute rest in a sitting position, from the right arm, and 
using an aneroid sphygmomanometer.
Echocardiography
Full echocardiographic procedures were performed at V1 and 
V2 in all participants. During V3 mainly the pulmonary artery 
dimension and pulmonary-to-systemic flow (Qp/Qs) ratio 
were assessed. 
Women were examined in a left decubitus position, us-
ing a Vivid S5 ultrasound (GE, Solingen, Germany) equipped 
with the multi-frequency harmonic transducer 3Sc-RS 
(1.3–4 MHz). All measurements were carried out according 
to joint recommendations of the American Society of Echo-
cardiography and European Association of Echocardiography 
[6, 7]. The right ventricular (RV) diameter was obtained from 
the basal one-third of the RV after adjustment from an apical 
four-chamber view to an RV-focused view. RV outflow tract 
diameter (RVOT-proximal) was assessed from a parasternal 
long-axis view (PLAX) at the end-diastolic phase. 
To calculate the Qp/QS ratio, RVOT-distal diameter was 
measured from a parasternal short-axis view, proximal to the 
pulmonary valve. From the same window, the PAD at the 
end-diastolic phase was also measured, approximately 1 cm 
below the pulmonary valve, using the leading-edge method. 
A PAD of 21 mm or less was considered to be within the 
reference range [7]. RV systolic pressure (RVSP) was deter-
mined from the peak tricuspid regurgitation jet velocity (V) 
and right atrial (RA) pressure (RVSP = 4 [V]2 + RA pressure). 
RA pressure was derived from the changes in the diameter of 
the inferior vena cava during respiration [7]. 
From the PLAX view in two-dimensional images, the 
left ventricular (LV) end-diastolic diameter (LVEDD) and 
LV end-systolic diameter (LVESD), interventricular septum 
diameter (IVSD), and posterior wall diameter (PWD) at 
the end-diastolic phase, as well as LV outflow tract at the 
mid-systolic phase, were measured. From the same view, 
after obtaining the best visualisation of the ascending 
aorta, the maximum aortic diameter at the end-diastolic 
phase was also measured. The areas of the right and left 
atria were planimetered in the apical four-chamber view. 
LV mass was calculated using the following equation: 
0.8 × (1.04 × [(LVEDD + PWD + IVSD)3 – (LVEDD)3] + 0.6), 
and then indexed to body surface area. Relative wall thick-
ness (RWT) was calculated using the following formula: 
RWT = 2 × PWD/LVEDD. LV end-diastolic (LVEDV) and 
end-systolic (LVESV) volumes, stroke volume, and ejection 
fraction were calculated using the biplane Simpson method. 
The LV cardiac output (LVCO) was calculated as the product 
between LV stroke volume and heart rate. Systemic vascular 
resistance (SVR) was estimated using the following formula: 
80 × mean arterial pressure/LVCO (dyn∙s∙cm–5), whereas 
mean arterial pressure was calculated using the following 
equation: systolic blood pressure + (2 × diastolic blood 
pressure)/3. Pulmonary artery acceleration time (ACT) was 
measured by sampling the RV outflow with pulsed-wave 
Doppler ultrasound.
Assessment of blood flow in uterine arteries
Women were examined in a supine position, and both arteries 
were visualised using a 4C RS (1.8–6.0 MHz) transducer (Vivid 
S5 ultrasound; GE). Blood flow was assessed by colour and 
pulsed-wave Doppler ultrasound. Before the measurements, 
the probe position was adjusted so that the artery angle was 
60° or less. The pulsatility index (PI) was calculated by the 
following equation: (peak systolic velocity – end-diastolic 
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velocity) / time-averaged velocity. The resistive index was 
estimated using the following formula: (peak systolic velocity 
– end-diastolic velocity) / peak systolic velocity. All measure-
ments were performed according to the applicable guidelines 
[8, 9]. The average values of three consecutive measurements 
were recorded. 
Intra-observer and inter-observer agreement
To calculate an intra-observer agreement for two-dimensional 
and Doppler ultrasound measurements, a re-analysis of 
10 randomly selected women was performed by a first in-
vestigator (blinded to the initial results) at least four weeks 
after the first examination. To assess the inter-observer agree-
ment, the same data sets were analysed by a second observer 
(A.F.N.). The agreement between the two measurements was 
presented using the 95% confidence interval (CI) determined 
as the mean of the differences ± 1.96 standard deviation (SD). 
Statistical analysis
Categorical variables were expressed as a proportion of the 
overall study population, and the differences were compared 
using the c2 or Fisher’s exact test. Continuous variables were 
presented as mean ± SD, and the Mann-Whitney U test was 
used for the comparison. The changes in PAD over time were 
assessed using the analysis of variance for repeated measurements 
and Bonferroni post hoc correction for multiple comparisons.
We calculated the sample size sufficient to show aorta 
augmentation, assuming that the PAD would also significantly 
increase in this study group. A sample size of 11 women 
would be required to detect an increase of 2 mm in the 
aorta diameter during pregnancy (between the first and third 
trimesters) at a p-value of less than 0.05 and a power of 90%. 
We recruited a sample that was twice this size to allow for 
patient dropout.
Correlations between the PAD and echocardiographic 
parameters were analysed using Pearson correlation. Differ-
ences with a p-value of less than 0.05 were considered sig-
nificant. A stepwise logistic regression analysis was performed 
to determine the independent predictors of pulmonary artery 
dilatation during normal pregnancy in the study population. 
The calibration and discrimination of the developed model 
were assessed using the Hosmer-Lemeshow test and area 
under the receiver operating characteristic curve analysis, 
respectively. For the analysis, pulmonary artery dilatation was 
defined as a PAD exceeding 21 mm.
The statistical analysis was performed using Statistica 
software, version 13.1 (Dell Software Int. Ltd., City Gate Park, 
Mahon, Cork, Ireland). 
RESULTS
Out of 86 women enrolled at baseline, 17 were excluded 
from the study (13 missed the second or follow-up visit, and 
four were diagnosed with pregnancy-induced hypertension). 
In total, 69 women were included in the analysis (Fig. 1). At 
baseline, the mean age of all participants was 29.5 ± 4.7 years 
(range, 19.8–42.3 years). On admission to the study, for 
29 (42%) women, it was the first pregnancy; for 21 (30.5%), 
the second; and for 19 (27.5%), the third or subsequent 
pregnancy. The course of gestation and labour was normal 
in all women and none of them suffered from dyspnoea. 
Demographic and echocardiographic findings for all studied 
women are presented in Table 1.
Pulmonary artery diameter
The PAD increased in the overall study population, from 
20.0 mm at V1 to 22.5 mm at V2, and it returned to normal 
values postpartum (19.5 mm; p < 0.001 vs. V2) (Fig. 2, Table 2). 
For statistical analysis, patients were classified into a group 
with pulmonary artery dilatation (PAD > 21 mm at any visit; 
group A) and a group with normal pulmonary artery dimension 
at both visits (group B). There were no differences between 
groups A and B with respect to age (29.1 vs. 29.6; p = 0.693), 
number of current pregnancy (2.3 vs. 1.8; p = 0.745), and 
prevalence of smoking before pregnancy (13% vs. 11%; 
p = 0.824). Furthermore, we did not observe significant dif-
ferences in body mass index and weight at visits V1 and V2 in 
the study subgroups.
The average mean increase in PAD between V1 and 
V2 was 20% in group A and 9% in group B (p < 0.001; Table 2). 
In group A, during V2, mild pulmonary artery dilatation 
(PAD < 26 mm) was detected in 17 (74%) women; moderate 
(26–29 mm), in four (17%); and severe (> 30 mm), in two (9%). 
The maximum increase in PAD was 10 mm in one participant. 
A detailed echocardiographic assessment did not reveal other 
abnormalities, including signs of intracardiac shunt (the Qp/Qs 
ratio was within the reference range in all women at each 
visit) or RV pressure overload (the maximum value of RVSP in 
the overall population was 20 mmHg). The postpartum visit 
showed normalisation of PAD among women in both study 
subgroups. Nevertheless, in group A, it was still augmented in 
comparison with group B (20.5 mm vs. 18.9 mm, respectively, 
Figure 1. Flowchart of the study population; FU — follow-up
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p = 0.002). The comparison of other haemodynamic, echo-
cardiographic, and uterine artery Doppler parameters in the 
study subgroups is presented in Tables 3, 4, and 5.
Predictors of pulmonary artery dilatation
The results of a univariate logistic regression analysis of pul-
monary artery dilatation during normal pregnancy are shown 
in Table 6. A multivariate logistic regression analysis showed 
that the RA area and LVESD measured at V2 were the only 
independent predictors of pulmonary artery dilatation (odds 
ratio [OR] 1.67; 95% CI 1.01–2.77; p = 0.047 and OR 1.51; 
95% CI 1.08–2.10; p = 0.016, respectively).
Haemodynamic correlations observed  
during 25–30 weeks of gestation
In the overall study population, PAD positively correlated 
with the following echocardiographic parameters: LVEDD 
Table 1. Demographic and echocardiographic data of all studied women (n = 69)
Visit 1 (10–14 week) Visit 2 (25–30 week) p
Body weight [kg] 67 ± 13 75 ± 12 < 0.001
BMI [kg/m2] 25 ± 6 27 ± 7 < 0.001
Heart rate [bpm] 78 ± 9  82 ± 9 < 0.001
Systolic BP [mmHg] 118 ± 18 116 ± 11 0.515
Diastolic BP [mmHg] 77 ± 9 74 ± 10 0.007
MAP [mmHg] 91 ± 9 88 ± 9 0.031
Echocardiographic parameters:
LVEF [%] 65 ± 5  64 ± 4 0.153
LVEDD [mm]  45 ± 4 47 ± 4 0.004
LVESD [mm] 29 ± 4 31 ± 4 0.002
LVEDV [mL] 89 ± 13 97 ± 15 < 0.001
LVESV [mL] 53 ± 18 61 ± 10 < 0.001
LV mass [g] 104 ± 22 118 ± 20 < 0.001
LV mass index [g/m2] 59 ± 11 65 ± 9 < 0.001
SVR [dyn∙s∙cm–5] 1658 ± 329 1415 ± 307 < 0.001
LVCO [L/min] 4 ± 0.9 5 ± 1 0.002
RWT 0.33 ± 0.07 0.36 ± 0.05 0.020
LA area [cm2] 17 ± 2 19 ± 2 < 0.001
LAV index [mL/m2] 28 ± 5 31 ± 6 < 0.001
RA area [cm2] 15 ± 2 15 ± 3 0.411
RVOT prox. [mm] 27 ± 3 27 ± 3 0.793
RVD [mm] 35 ± 3 36 ± 3 0.086
ACT [ms] 120 ± 12 117± 14 0.373
TAPSE [mm] 26 ± 3 26 ± 4 0.588
Aorta [mm] 26 ± 3 27 ± 2 0.017
Data are presented as mean ± standard deviation. ACT — acceleration time; BMI — body mass index; BP — blood pressure; LA — left atrium; 
LAV — left atrial volume; LV — left ventricular; LVCO — left ventricular cardiac output; LVEDD — left ventricular end-diastolic diameter;  
LVEDV — left ventricular end-diastolic volume; LVEF — left ventricular ejection fraction; LVESD — left ventricular end-systolic diameter;  
MAP — mean arterial pressure; RA — right atrium; RVD — right ventricular diameter; RVOT — right ventricular outflow tract; RWT — relative  
wall thickness; SVR — systemic vascular resistance; TAPSE — tricuspid annular plane systolic excursion
Figure 2. Changes in pulmonary artery diameter during pre-
gnancy and postpartum in the overall group (n = 69). Data 
are presented as mean ± standard deviation; #p < 0.05 vs.  
visit 1; &p < 0.05 vs. postpartum
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(r = 0.411; p = 0.003), LVESD (r = 0.345; p = 0.006), LVEDV 
(r = 0.308; p = 0.016), left atrial area (r = 0.334; p = 0.009), 
LVCO (r = 0.338; p = 0.011), and aortic diameter (r = 0.399; 
p = 0.004). Moreover, there was a negative linear relation-
ship between PAD and SVR (r = –0.307; p = 0.025) and PI 
(r = –0.307; p = 0.007; Fig. 3).
Measurement variability 
The inter-observer agreement for echocardiographic measure-
ments (mean ± 1.96 SD) was: 0.3 ± 2.4 mm for PAD at V1, 
–0.5 ± 2.2 mm for PAD at V2, and 0.4 ± 1.7 mm for PAD at 
postpartum visit, whereas the intra-observer variability for the 
same parameters was equal to 0.8 ± 2.4 mm, 0.7 ± 2.9 mm, 
and –0.6 ± 1.9 mm, respectively. For LV measurements the 
inter-observer agreement was 0.6 ±3.1 mm for LV diameters, 
0.01 ±1.4 mm for wall thickness, 1.4 ± 15 ml for LVEDV, 
and 0.9 ± 12 mL for LVESV. 
Table 2. Changes in pulmonary artery diameter (PAD) in the study population and in the study groups (A and B)
Visit 1
(10–14 week)
Visit 2
(25–30 week)
Postpartum
(12–38 week)
p
PAD (n = 69) [mm] 20 ± 0.3 22 ± 0.4#* 19 ± 0.2 < 0.001
Group A (n =23) [mm] 21 ± 0.7 25 ± 0.8#* 20 ± 0.6 < 0.001
Group B (n = 46) [mm] 19 ± 0.3 21 ± 0.2#* 19 ± 0.2 < 0.001
Data are presented as mean ± standard deviation. P-values derived from ANOVA for repeated measurements.
#p < 0.05 vs. visit 1 using Bonferroni post hoc correction for repeated measurements. 
*p < 0.05 vs. postpartum using Bonferroni post hoc correction for repeated measurements.
Table 3. Haemodynamic data in the study groups
Group A (n = 23)  
Mean PAD > 21 mm
Group B (n = 46) 
Mean PAD ≤ 21 mm
p
Parameters at visit 1 (10–14 weeks):
Heart rate [bmp] 77 ± 10 78 ± 9 0.283
Systolic BP [mmHg] 121 ± 11 116 ± 19 0.283
Diastolic BP [mmHg] 75 ± 10 77 ± 8 0.471
MAP [mmHg] 91 ± 11 90 ± 9 0.983
SVR [dyn∙s∙cm–5] 1653 ± 353 1599 ± 331 0.585
LVCO [L/min] 4 ± 0.8 5 ± 0.9 0.322
Parameters at visit 2 (25–30 weeks):
Heart rate [bpm] 85 ± 11* 88 ± 9** 0.205
Systolic BP [mmHg] 115 ± 13 117 ± 11 0.515
Diastolic BP [mmHg] 74 ± 11 74 ± 9* 0.968
MAP [mmHg] 87 ± 11 88 ± 9* 0.778
SVR [dyn∙s∙cm–5] 1270 ± 167** 1460 ± 362 0.044
LVCO [L/min] 6 ± 1** 4 ± 1# 0.002
Data are presented as mean ± standard deviation. Abbreviations — see Table 1. *p < 0.05 compared with visit 1; **p < 0.005 compared with 
visit 1; #p < 0.00001 compared with visit 1
The intra-observer variability showed values of 
0.8 ± 3.5 mm, –0.01 ± 1.8 mm, 2.5 ± 16 mL, and 
–1.5 ± 12 mL, respectively.
DISCUSSION
Most of the haemodynamic changes and subsequent cardiac 
remodelling observed in all women in our study are charac-
teristic of normal pregnancy and are consistent with findings 
from other studies [1, 2, 10–14]. This applies to an increase in 
heart rate, LV stroke volume, and LVCO, and to a decrease in 
SVR. Our results are comparable with those of other studies, 
although the absolute values of stroke volume were smaller 
in comparison with those reported in other studies [2, 11, 
12, 15]. For example, in a study by Savu et al. [2] stroke 
volume was higher than that in our study, while LVCO was 
similar. These discrepancies may have resulted from the 
differences in methodology. To assess stroke volume Savu et 
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al. [2] used the Doppler technique, while we used the biplane 
Simpson method for the calculation. Surprisingly, unlike 
other studies, which reported both RA and RV enlargement 
[1, 14, 15], we observed only mild RA dilatation in group 
A (Table 4). The reason why we did not observe RV enlarge-
ment remains unclear and requires further examination. The 
Table 4. Echocardiographic characteristics of the study groups
Group A (n = 23) 
Mean PAD > 21 mm
Group B (n = 46) 
Mean PAD ≤ 21 mm
p
Parameters at visit 1 (10–14 weeks):
LVEF [%] 64 ± 5 65 ± 6 0.433
LVEDD [mm] 46 ± 4 45 ± 4 0.680
LVESD [mm] 30 ± 4 29 ± 4 0.608
LVEDV [mL] 90 ± 13 89 ± 14 0.813
LVSV [mL] 58 ± 9 59 ± 10 0.751
LV mass [g] 112 ± 24 99 ± 20 0.023
LV mass index [g/m2] 64 ± 13 57 ± 8 0.022
LV mass/h2.7 [g/m2.7] 28 ± 6 26 ± 6 0.102
RWT 0.34 ± 0.1 0.34 ± 0.05 0.991
LA area [cm2] 18 ± 2 17 ± 2 0.270
LAV index [mL/m2] 29 ± 5 28 ± 4 0.390
RA area [cm2] 15 ± 2 15 ± 2 0.088
RVOT prox. [mm]  26 ± 3 27 ± 3 0.691
RVD [mm] 35 ± 3 35 ± 2 0.625
ACT [ms] 119 ± 11 121 ± 12 0.516
TAPSE [mm] 27 ± 3 26 ± 3 0.459
RVSP [mmHg] 16 ± 2 12 ± 5 0.746
Aorta [mm] 27 ± 3 26 ± 3 0.175
Parameters at visit 2 (25–30 weeks):
LVEF [%] 63 ± 3 63 ± 4 0.443
LVEDD [mm] 48 ± 3* 46 ± 3 0.019
LVESD [mm] 33 ± 5** 29 ± 3* 0.001
LVEDV [mL] 103 ± 14** 93 ± 15 0.024
LVSV [mL] 65 ± 9* 59 ± 9 0.025
LV mass [g] 128 ± 17** 113 ± 19# 0.005
LV mass index [g/m2] 69 ± 9* 62 ± 8** 0.012
LV mass/h2.7 [g/m2.7] 33 ± 4** 29 ± 6*** 0.058
RWT 0.36 ± 0.05 0.37 ± 0.04 0.762
LA area [cm2] 19 ± 2* 18 ± 2** 0.412
LAV index [mL/m2] 32 ± 7* 31 ± 5** 0.704
RA area [cm2] 16 ± 2* 15 ± 3 0.087
RVOT prox. [mm] 26 ± 3 27 ± 3 0.196
RVD [mm] 36 ± 3 36 ± 3 0.754
ACT [ms] 120 ± 16 118 ± 14 0.804
TAPSE [mm] 26 ± 3 27 ± 4 0.318
RVSP [mmHg] 15 ± 3 18 ± 4 0.171
Aorta [mm] 28 ± 3 26 ± 2 0.005
Data are presented as mean ± standard deviation. LVSV — left ventricular stroke volume; RVSP — right ventricular systolic pressure; other  
abbreviations — see Table 1. *p < 0.05 compared with visit 1; **p < 0.005 compared with visit 1; ***p < 0.0001 compared with visit 1;  
#p < 0.00001 compared with visit 1
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possible explanation of these discrepancies may result from 
the difference in the schedule of visits (especially V1 and V2) 
in our study in comparison with those reported in other 
studies. Other investigators, who planned three or four visits 
during pregnancy, observed RA dilatation between the first 
and third trimesters (after 34 gestational weeks), when the 
increase in plasma volume is the highest [14, 15]. Moreo-
ver, Melchiorre et al. [14] reported that tricuspid annular 
plane systolic excursion (TAPSE) declined significantly near 
term and returned to normal values postpartum, whereas 
in a study by Ducas et al. [15], the TAPSE values between 
the first and third trimesters were stable, which is in line 
with our results. 
To the best of our knowledge, we were the first to show 
that during pregnancy the PAD may increase by 1 to 10 mm 
(average 2 mm), especially between the second and third 
trimesters in comparison with the first trimester, and it may 
return to the reference values postpartum. These morpho-
logical changes of the pulmonary artery in our study had 
no influence on the course of any pregnancies and labour. 
There are a few possible explanations for this phenomenon. 
One possibility is an undiagnosed left-to-right shunt before 
pregnancy, especially atrial septal defect type 2. To exclude 
this, we assessed the Qp/Qs ratio, which was within the ref-
erence range in all women. Another possibility is pulmonary 
embolism. Nevertheless, the clinical probability of this disease 
was low according to the Wells rule (0 points) in all studied 
women. The echocardiographic examination excluded RV 
pressure overload in the overall study population. Although 
pregnancy increases the risk of venous thromboembolism, 
the prevalence of pulmonary embolism in pregnant women is 
low (six per 10,000 pregnancies) [16], whereas asymptomatic 
pulmonary artery dilatation occurred in every third woman 
in our study. The mean pulmonary artery pressure can be 
also estimated noninvasively using Mahan’s equation, which is 
based on ACT [16]. However, ACT is correlated with LVCO and 
heart rate; it increases with increasing LVCO levels and decreases 
with increasing heart rate. As both LVCO and heart rate increase 
during pregnancy, the ACT should be interpreted with caution. 
Pulmonary artery dilatation may be related to volume 
overload. In group A, we found a significant increase in RA 
and left atrial areas, LV dimensions and volume, and in stroke 
Table 5. Assessment of blood flow in uterine arteries in the study groups
Group A (n = 23) 
PAD > 21 mm
Group B (n = 46) 
PAD ≤ 21 mm
p
Parameters at visit 1 (10–14 week):
PI 1.3 ± 0.6 1.5 ± 0.5 0.244
RI 0.6 ± 0.2 0.7 ± 0.1 0.234
Parameters at visit 2 (25–30 week):
PI 0.5 ± 0.1 0.7 ± 0.2 0.103
RI 0.4 ± 0.1 0.4 ± 0.1 0.278
Data are presented as mean ± standard deviation. PAD — pulmonary artery diameter; PI — pulsatility index; RI — resistive index
Table 6. Univariate logistic regression analysis of pulmonary 
artery dilatation during normal pregnancy
Variable Univariate analysis
OR (95% CI) p
PAD V1 2.46 (1.45–4.17) < 0.001
Aorta V1 1.52 (1.05–2.18) 0.007
LV mass V1 1.04 (1.01–1.07) 0.017
LVEDD V2 1.28 (1.04–1.58) 0.009
LVESD V2 1.24 (1.02–1.51) 0.021
LVSV V2 1.07 (1.00–1.16) 0.036
RA area V2 1.55 (1.10–2.12) 0.002
LV mass V2 1.07 (1.02–1.21) < 0.001
Aorta V2 1.76 (1.12–2.77) 0.004
CI — confidence interval; OR — odds ratio; V1 — visit 1; V2 — visit 2; 
other abbreviations — see tables 1, 4, 5
Figure 3. Correlation between pulmonary artery diameter and 
aorta at visit 2 (p < 0.05; r = 0.399)
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volume, as compared with baseline values (Table 4). A higher 
LV mass indexed to the body surface area and to height 
(h)2.7 in group A in comparison with group B during V2 was 
probably also secondary to increased volume overload. This 
observation shows that volume overload and cardiovascular 
adaptations to these changes may be significantly different in 
healthy pregnant women. 
We also observed a negative association between PAD 
and SVR, as well as the PI in the uterine artery measured dur-
ing the second visit. This revealed that PAD is also related to 
reduced afterload. These changes observed in our study are 
contrary to those occurring in pre-eclampsia, such as reduced 
blood volume and increased SVR and PI [17, 18]. Previous 
studies showed that relaxin, an endothelium-dependent 
hormone peptide, along with progesterone and oestrogen, 
prevents an increase in systolic blood pressure, and by stimu-
lating vasopressin secretion and drinking provides increased 
water retention [19, 20]. Relaxin acts via nitrate oxygen, and it 
has been proven that its deficiency may lead to pre-eclampsia 
[17, 21]. Although we did not examine the level of relaxin in 
our study, the volume overload observed in our participants 
with pulmonary artery dilatation may be partially related to this 
hormone. This potential association requires further research. 
In our study, PAD was also positively correlated with 
aortic diameter. Other researchers proved that increased 
aortic distensibility, along with lowered stiffness indices during 
pregnancy, are caused by intrinsic changes in the arterial wall 
and are unrelated to afterload [4, 5].
These changes in the aortic wall are probably mediated 
by oestrogens and include fragmentation of reticular fibres, 
loss of normal corrugation of elastic fibres, a reduction in 
acid mucopolysaccharides, and hypertrophy and hyperplasia 
of smooth muscle cells [22]. This similar mechanism may 
also be partially responsible for pulmonary artery dilatations 
during gestation. In a case report by Veil-Picard et al. [23], 
symptomatic hypoxaemia during pregnancy was described 
as a result of transient pulmonary arteriovenous dilatation. 
In this patient, oestrogen-mediated augmentation and pro-
liferation of blood vessels was the probable mechanism, and 
all symptoms resolved postpartum along with spontaneous 
regression of vascular changes. Nevertheless, despite a com-
puted tomography scan and numerous echocardiographic 
examinations, the pulmonary artery dilatation was not de-
scribed in this case report. Furthermore, none of our patients 
suffered from dyspnoea. 
In contrast to most longitudinal pregnancy studies, instead 
of three visits, one during each trimester, we scheduled only 
two visits with an echocardiographic assessment. However, 
despite this limitation our data allow the observation of 
morphological and haemodynamic changes throughout 
gestation. In addition, unlike other studies, we did not enrol 
a control group or assess parameters other than PAD at the 
postpartum visit because it was not absolutely necessary for 
our conclusions. 
In summary, this study describes pulmonary artery dilata-
tion in healthy pregnant women without any other abnormal 
echocardiographic findings and without the signs of shunt or 
pulmonary embolism. These changes in PAD are associated 
with volume overload, low vascular resistance, and possibly 
intrinsic changes in the arterial wall. They coexist with physi-
ological cardiac remodelling during pregnancy, and they usu-
ally regress postpartum. 
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WHAT IS NEW?
In this paper, we report that the pulmonary artery diameter may increase by 1 to 10 mm in healthy pregnant women 
and return to the reference values postpartum. To the best of our knowledge, we are the first to report this observation. 
These changes in pulmonary artery diameter are associated with volume overload and low vascular resistance. This is of 
importance because cardiovascular disease remains the main reason for maternal death during pregnancy and postpartum. 
A profound knowledge of the physiological adaptation of the cardiovascular system to normal pregnancy is essential in 
order to better distinguish pregnant women who require further examination from those who do not. 
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